Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. [electronic resource]
Producer: 20100512Description: 627-37 p. digitalISSN:- 1460-2105
- Adult
- Aged
- Analysis of Variance
- Biomarkers, Tumor -- analysis
- Breast Neoplasms -- chemistry
- Carcinoma, Ductal, Breast -- diagnosis
- Carcinoma, Intraductal, Noninfiltrating -- chemistry
- Case-Control Studies
- Cyclin-Dependent Kinase Inhibitor p16
- Cyclooxygenase 2 -- analysis
- Disease Progression
- Female
- Humans
- Immunohistochemistry
- Incidence
- Ki-67 Antigen -- analysis
- Mastectomy, Segmental
- Middle Aged
- Neoplasm Proteins -- analysis
- Neoplasm Recurrence, Local -- diagnosis
- Odds Ratio
- Palpation
- Predictive Value of Tests
- Prognosis
- Receptor, ErbB-2 -- analysis
- Receptors, Estrogen -- analysis
- Receptors, Progesterone -- analysis
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Survival Analysis
- Time Factors
- Tumor Suppressor Protein p53 -- analysis
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.